Indian Journal of Critical Care Medicine

Register      Login



Volume / Issue

Online First

Related articles

VOLUME 25 , ISSUE 6 ( June, 2021 ) > List of Articles

Original Article

Clinicoepidemiological Features and Mortality Analysis of Deceased Patients with COVID-19 in a Tertiary Care Center

Ridhima Bhatia, Kshitija Kulshrestha, Renjith Viswanath, Karthik V Iyer, Sulagna Bhattacharjee, Ajisha Aravindan, Anju Gupta, Arshed Ayub, Shailender Kumar, Kellika Prakash, Debesh Bhoi, Rajesh Malhotra, Randeep Guleria

Keywords : Clinicoepidemiological features, Comorbidities, COVID-19 deceased, ICU, Mortality analysis, Multi-organ dysfunction syndrome

Citation Information : Bhatia R, Kulshrestha K, Viswanath R, Iyer KV, Bhattacharjee S, Aravindan A, Gupta A, Ayub A, Kumar S, Prakash K, Bhoi D, Malhotra R, Guleria R. Clinicoepidemiological Features and Mortality Analysis of Deceased Patients with COVID-19 in a Tertiary Care Center. Indian J Crit Care Med 2021; 25 (6):622-628.

DOI: 10.5005/jp-journals-10071-23848

License: CC BY-NC 4.0

Published Online: 01-06-2021

Copyright Statement:  Copyright © 2021; The Author(s).


Background and objective: A large number of studies describing the clinicoepidemiological features of coronavirus disease-2019 (COVID-19) patients are available but very few studies have documented similar features of the deceased. This study was aimed to describe the clinicoepidemiological features and the causes of mortality of COVID-19 deceased patients admitted in a dedicated COVID center in India. Methodology: This was a retrospective study done in adult deceased patients admitted in COVID ICU from April 4 to July 24, 2020. The clinical features, comorbidities, complications, and causes of mortality in these patients were analyzed. Pediatric deceased were analyzed separately. Results: A total of 654 adult patients were admitted in the ICU during the study period and ICU mortality was 37.7% (247/654). Among the adult deceased, 65.9% were males with a median age of 56 years [interquartile range (IQR), 41.5–65] and 94.74% had one or more comorbidities, most common being hypertension (43.3%), diabetes mellitus (34.8%), and chronic kidney disease (20.6%). The most common presenting features in these deceased were fever (75.7%), cough (68.8%), and shortness of breath (67.6%). The mean initial sequential organ failure assessment score was 9.3 ± 4.7 and 24.2% were already intubated at the time of admission. The median duration of hospital stay was 6 days (IQR, 3–11). The most common cause of death was sepsis with multi-organ failure (55.1%) followed by severe acute respiratory distress syndrome (ARDS) (25.5%). All pediatric deceased had comorbid conditions and the most common cause of death in this group was severe ARDS. Conclusion: In this cohort of adult deceased, most were young males with age less than 65 years with one or more comorbidities, hypertension being the most common. Only 5% of the deceased had no comorbidities. Sepsis with multi-organ dysfunction syndrome was the most common cause of death.

  1. Worldometer info. World/Countries/India; 2020. Available from: [Accessed on January 17, 2020].
  2. Bal A, Agrawal R, Vaideeswar P, Arava S, Jain A. COVID-19: an up-to-date review – from morphology to pathogenesis. Indian J Pathol Microbiol 2020;63(3):358–366. DOI: 10.4103/IJPM.IJPM_779_20.
  3. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020;323(13):1239–1242. DOI: 10.1001/jama.2020.2648.
  4. Behzad S, Aghaghazvini L, Radmard AR, Gholamrezanezhad A. Extrapulmonary manifestations of COVID-19: radiologic and clinical overview. Clin Imaging 2020;66:35–41. DOI: 10.1016/j.clinimag.2020.05.013.
  5. Zheng KI, Feng G, Liu WY, Targher G, Byrne CD, Zheng MH. Extrapulmonary complications of COVID-19: a multisystem disease? J Med Virol 2020;10.1002/jmv.26294. DOI: 10.1002/jmv.26294.
  6. Noor FM, Islam MM. Prevalence and associated risk factors of mortality among COVID-19 patients: a meta-analysis. J Community Health 2020;45(6):1270–1282. DOI: 10.1007/s10900-020-00920-x.
  7. Gupta S, Hayek SS, Wang W, Chan L, Mathews KS, Melamed ML, et al. Factors associated with death in critically ill patients with coronavirus disease 2019 in the US. JAMA Intern Med 2020;180(11):1–12. DOI: 10.1001/jamainternmed.2020.3596.
  8. Grasselli G, Greco M, Zanella A, Albano G, Antonelli M, Bellani G. Risk factors associated with mortality among patients with COVID-19 in intensive care units in Lombardy, Italy. JAMA Intern Med 2020;180(10):1345–1355. DOI: 10.1001/jamainternmed.2020.3539.
  9. Cummings MJ, Baldwin MR, Abrams D, Jacobson SD, Meyer BJ, Balough EM, et al. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study. Lancet 2020;395(10239):1763–1770. DOI: 10.1016/S0140-6736(20)31189-2.
  10. Rivera-Izquierdo M, Del Carmen Valero-Ubierna M, R-delAmo JL, Fernández-García MÁ, Martínez-Diz S, Tahery-Mahmoud A, et al. Sociodemographic, clinical and laboratory factors on admission associated with COVID-19 mortality in hospitalized patients: a retrospective observational study. PLoS One 2020;15(6):e0235107. DOI: 10.1371/journal.pone.0235107.
  11. Du RH, Liu LM, Yin W, Wang W, Guan LL, Yuan ML, et al. Hospitalization and critical care of 109 decedents with COVID-19 pneumonia in Wuhan, China. Ann Am Thorac Soc 2020;17(7):839–846. DOI: 10.1513/AnnalsATS.202003-225OC.
  12. Du Y, Tu L, Zhu P, Mu M, Wang R, Yang P, et al. Clinical features of 85 fatal cases of COVID-19 from Wuhan. A retrospective observational study. Am J Respir Crit Care Med 2020;201(11):1372–1379. DOI: 10.1164/rccm.202003-0543OC.
  13. Yang F, Shi S, Zhu J, Shi J, Dai K, Chen X. Analysis of 92 deceased patients with COVID-19. J Med Virol 2020;92(11):2511–2515. DOI: 10.1002/jmv.25891.
  14. Wang Y, Lu X, Li Y, Chen H, Chen T, Su N, et al. Clinical course and outcomes of 344 intensive care patients with COVID-19. Am J Respir Crit Care Med 2020;201(11):1430–1434. DOI: 10.1164/rccm.202003-0736LE.
  15. Palmieri L, Vanacore N, Donfrancesco C, Lo Noce C, Canevelli M, Punzo O, et al. Clinical characteristics of hospitalized individuals dying with COVID-19 by age group in Italy. J Gerontol A Biol Sci Med Sci 2020;75(9):1796–1800. DOI: 10.1093/gerona/glaa146.
  16. Biagi A, Rossi L, Malagoli A, Zanni A, Sticozzi C, Comastri G, et al. Clinical and epidemiological characteristics of 320 deceased patients with COVID-19 in an Italian Province: a retrospective observational study. J Med Virol 2020;92(11):2718–2724. DOI: 10.1002/jmv.26147.
  17. Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy. JAMA 2020;323(16):1574–1581. DOI: 10.1001/jama.2020.5394.
  18. Quah P, Li A, Phua J. Mortality rates of patients with COVID-19 in the intensive care unit: a systematic review of the emerging literature. Crit Care 2020;24(1):285. DOI: 10.1186/s13054-020-03006-1.
  19. Rajgor DD, Lee MH, Archuleta S, Bagdasarian N, Quek SC. The many estimates of the COVID-19 case fatality rate. Lancet Infect Dis 2020;20(7):776–777. DOI: 10.1016/S1473-3099(20)30244-9.
  20. Pellaud C, Grandmaison G, Pham Huu Thien HP, Hoa Phong PH, Baumberger M, Carrel G, et al. Characteristics, comorbidities, 30-day outcome and in-hospital mortality of patients hospitalised with COVID-19 in a Swiss area – a retrospective cohort study. Swiss Med Wkly 2020;150:w20314. DOI: 10.4414/smw.2020.20314.
  21. United Nations, Department of Economic and Social Affairs. World population ageing 2019 highlights; 2019. Available from:
  22. Singh AK, Gillies CL, Singh R, Singh A, Chudasama Y, Coles B, et al. Prevalence of co-morbidities and their association with mortality in patients with COVID-19: a systematic review and meta-analysis. Diabetes Obes Metab 2020;22(10):1915–1924. DOI: 10.1111/dom.14124.
  23. Singh AK, Gupta R, Misra A. Comorbidities in COVID-19: outcomes in hypertensive cohort and controversies with renin angiotensin system blockers. Diabetes Metab Syndr 2020;14(4):283–287. DOI: 10.1016/j.dsx.2020.03.016.
  24. Sun YJ, Feng YJ, Chen J, Li B, Luo ZC, Wang PX. Clinical features of fatalities in patients with COVID-19. Disaster Med Public Health Prep 2020;1–3. DOI: 10.1017/dmp.2020.235.
  25. Liu S, Yao N, Qiu Y, He C. Predictive performance of SOFA and qSOFA for in-hospital mortality in severe novel coronavirus disease. Am J Emerg Med 2020;38(10):2074–2080. DOI: 10.1016/j.ajem.2020.07.019.
  26. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult in patients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020;395(10229):1054–1062. DOI: 10.1016/S0140-6736(20)30566-3.
  27. Martinez AC, Dewaswala N, Tuarez FR, Pino J, Chait R, Chen K, et al. Validation of SOFA score in critically ill patients with COVID-19. Chest 2020;158(4):A613. DOI: 10.1016/j.chest.2020.08.577.
  28. Chen Y, Li T, Ye Y, Chen Y, Pan J. Impact of fundamental diseases on patients with COVID-19. Disaster Med Public Health Prep 2020:1–6. DOI: 10.1017/dmp.2020.139.
  29. Ahmed AR, Ebad CA, Stoneman S, Satti MM, Conlon PJ. Kidney injury in COVID-19. World J Nephrol 2020;9(2):18. DOI: 10.5527/wjn.v9.i2.18.
  30. Keeley P, Buchanan D, Carolan C, Pivodic L, Tavabie S, Noble S. Symptom burden and clinical profile of COVID-19 deaths: a rapid systematic review and evidence summary. BMJ Support Palliat Care 2020;10(4):381–384. DOI: 10.1136/bmjspcare-2020-002368.
  31. Chang TH, Wu JL, Chang LY. Clinical characteristics and diagnostic challenges of pediatric COVID-19: a systematic review and meta-analysis. J Formos Med Assoc 2020;119(5):982–989. DOI: 10.1016/j.jfma.2020.04.007.
  32. Patel NA. Pediatric COVID-19: systematic review of the literature. Am J Otolaryngol 2020;41(5):102573. DOI: 10.1016/j.amjoto.2020.102573.
  33. Jeng MJ. Coronavirus disease 2019 in children: current status. J Chin Med Assoc 2020;83(6):527–533. DOI: 10.1097/JCMA.0000000000000323.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.